Form 4 for WGS GeneDx Holdings Corp.
Accepted 2025-02-07 00:00:00 ET · period of report 2025-02-05 · accession 0001415889-25-003339 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-07 | 2025-02-05 | WGS | RUCH JOSHUA | Dir | M - OptEx | $7.89 | +5,816 | 16.8K | +53% | +$45.9K |
| D | 2025-02-07 | 2025-02-05 | WGS | RUCH JOSHUA | Dir | M - OptEx | $0.00 | -5,816 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-02-05 | M | A | 5,816 | $7.89 | 16,799 | D | — | — | (F1) Reflects an acquisition of Class A Common Stock from the exercise of stock option at an exercise price of $7.89 per share as described in Table II. The increase in beneficial ownership of Class A Common Stock resulting therefrom is indicated in Table I. |
| 2 | Derivative | Stock Option (right to buy) | 2025-02-05 | M | D | 5,816 | $0.00 | 0 | D | $7.89 · — to 2033-07-20 | 5,816 Class A Common Stock | (F3) The option is fully vested. |